Reading this on a mobile device? Try our optimized mobile version here:

November 20, 2012
Sign upForwardArchiveAdvertise
News for Invasive/Interventional Cardiologists

  Top Stories 
  • Medical societies update guidelines for stable ischemic heart disease
    An expert panel representing seven societies including SCAI has issued guidelines to update the treatment approach for stable ischemic heart disease. The guidelines include 48 recommendations on diagnosis, risk assessments and treatment options including revascularization. Dr. Ajay Kirtane weighed in on the treatment guidelines, saying physicians must also account for patient preference. "We have abundant data demonstrating that patients feel better than they would with medical therapy, and many patients would choose [revascularization] because they don't want to take anti-anginal medications," he said. (11/19), (Montreal) (free registration) (11/19), Forbes (11/19) LinkedInFacebookTwitterEmail this Story
  • Societies including SCAI release troponin consensus statement
    A new consensus statement from seven societies including SCAI evaluates recent findings relative to troponin testing and aims to provide guidance to clinicians on ordering tests and evaluating their results. "We need to be thinking about why we are ordering the troponin test before we order it," said Dr. L. Kristin Newby, a Duke University Medical Center professor who served as co-chair of the writing committee. "We hope this document provides a road map to help clinicians be more deliberate when ordering these tests and interpreting the results." Family Practice News (11/12) LinkedInFacebookTwitterEmail this Story
  • Other News
  Policy & Professional News 
  • Allocation bias explains differences between RCT, registry studies
    Allocation bias can have a significant effect on cardiovascular treatment findings, according to an analysis that explored cases of conflicting results between randomized, controlled trials and registry studies. RCTs have consistently favored primary angioplasty in STEMI over fibrinolysis, while registry studies tend to find equivalent survival for both approaches. The new research found that just a few high-risk patients masked the survival benefit of percutaneous coronary intervention. "Once this allocation bias is accounted for, registries predict that primary PCI has 22% lower long-term mortality than fibrinolysis," said Dr. Sayan Sen of London's St. Mary's Hospital. (11/19), MedPage Today (free registration) (11/16) LinkedInFacebookTwitterEmail this Story
  • Quality incentives may save lives, U.K. study finds
    A University of Manchester study found linking hospital payments to performance on 28 quality measures, including heart attack treatment, was associated with a 1.3% drop in mortality rates. The improvements were not found outside the specialties included in the program, which offered up to a 4% incentive payment for hospitals that did well on the quality measures. The Washington Post/Wonkblog (11/12) LinkedInFacebookTwitterEmail this Story
  • Other News
  Medical Developments 
  • Physicians support expanded use of outpatient PCI
    Same-day discharge for percutaneous coronary intervention patients can become a more common practice at U.S. hospitals without posing additional risks, according to a group of physicians who discussed the topic at the American Heart Association annual meeting earlier this month. Low complication rates and safety beyond the six-hour mark make PCI ripe for same-day-discharge as long as patient education and support is a high priority, experts said. SCAI's criteria for outpatient PCI were cited as a resource for identification of candidate patients. (Montreal) (free registration) (11/12) LinkedInFacebookTwitterEmail this Story
  • Study assesses post-TAVR complications
    Cerebrovascular events in patients who have undergone transcatheter valve replacement are often tied to length of time since surgery, according to an observational study published in the journal Circulation. Researchers found earlier post-TAVR events were tied to procedural issues, with events beyond the 30-day mark tied to comorbidities. (11/16) LinkedInFacebookTwitterEmail this Story
  • Other News
  SCAI News 
  • Don't miss next week's SCAI/ACC/HRS webinar on sweeping changes coming to cardiology coding
    You can't afford to miss next week's SCAI/ACC/HRS webinar on major changes coming to cardiology in 2013. This Web-based educational program is designed to prepare you and your billing staff for a complete restructuring of the codes and coding conventions for percutaneous coronary interventions (PCI), ablation procedures and more. Featuring nationally recognized experts Robert Piana, MD, FACC, Amit J. Shanker, MD, FHRS, Art Lee, MD, FSCAI, and Cliff Kavinsky, MD, PhD, FSCAI, the webinar will take place from 3 to 5 p.m. ET on Wednesday, Nov. 28. RSVP now for this FREE webinar. LinkedInFacebookTwitterEmail this Story
Learn more about SCAI ->Join SCAI  |  SCAI 2013  |  SCAI Education & Meetings  |  SCAI e-Learning
Advocacy Update  |  Information for Your Patients

A good man with a good conscience doesn't walk so fast."
--Georg Büchner,
German writer

LinkedInFacebookTwitterEmail this Story

The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.

The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent SCAI SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information